C Werning

590 total citations
56 papers, 400 citations indexed

About

C Werning is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, C Werning has authored 56 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in C Werning's work include Hormonal Regulation and Hypertension (17 papers), Electrolyte and hormonal disorders (9 papers) and Adrenal and Paraganglionic Tumors (5 papers). C Werning is often cited by papers focused on Hormonal Regulation and Hypertension (17 papers), Electrolyte and hormonal disorders (9 papers) and Adrenal and Paraganglionic Tumors (5 papers). C Werning collaborates with scholars based in Germany and Switzerland. C Werning's co-authors include W Siegenthaler, P Weidmann, Klaus Baumann, W. Vetter, W Vetter, H. Vetter, Walter Ziegler, Mathieu Berger, H Sulser and H. U. Schweikert and has published in prestigious journals such as Circulation, The American Journal of Medicine and Clinical Endocrinology.

In The Last Decade

C Werning

54 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Werning Germany 11 140 140 95 92 88 56 400
Quentin B. Deming United States 10 101 0.7× 206 1.5× 73 0.8× 135 1.5× 66 0.8× 17 486
N. Papanicolaou France 13 134 1.0× 96 0.7× 39 0.4× 141 1.5× 119 1.4× 38 547
P. Speckart United States 8 97 0.7× 189 1.4× 50 0.5× 55 0.6× 125 1.4× 9 589
Francis L. Stutzman United States 9 82 0.6× 110 0.8× 73 0.8× 35 0.4× 79 0.9× 12 531
E. Podjarny Israel 14 107 0.8× 71 0.5× 59 0.6× 115 1.3× 71 0.8× 48 707
T. Mountokalakis Greece 11 54 0.4× 48 0.3× 105 1.1× 126 1.4× 45 0.5× 44 446
Leroy E. Duncan United States 11 220 1.6× 239 1.7× 181 1.9× 123 1.3× 126 1.4× 15 712
Lawrence Levine United States 6 70 0.5× 64 0.5× 30 0.3× 209 2.3× 118 1.3× 8 415
Markus Küng United States 10 128 0.9× 64 0.5× 49 0.5× 158 1.7× 69 0.8× 20 489
Andre J. Premen United States 13 123 0.9× 124 0.9× 137 1.4× 96 1.0× 78 0.9× 22 526

Countries citing papers authored by C Werning

Since Specialization
Citations

This map shows the geographic impact of C Werning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Werning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Werning more than expected).

Fields of papers citing papers by C Werning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Werning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Werning. The network helps show where C Werning may publish in the future.

Co-authorship network of co-authors of C Werning

This figure shows the co-authorship network connecting the top 25 collaborators of C Werning. A scholar is included among the top collaborators of C Werning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Werning. C Werning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Werning, C, et al.. (1988). Assessment of indapamide in elderly hypertensive patients with special emphasis on well-being. The American Journal of Medicine. 84(1B). 104–108. 8 indexed citations
3.
Werning, C, et al.. (1988). Assessment of indapamide in elderly hypertensive patients with special emphasis on well-being. The American Journal of Medicine. 84(1). 104–108. 3 indexed citations
4.
Werning, C. (1978). [Results of a study with the antihypertensive agent Torrat].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 117(12). 1924–9. 1 indexed citations
5.
Werning, C, Dale E. Hammerschmidt, & Hartmut Kaiser. (1978). [Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].. PubMed. 29(40). 1570–5. 3 indexed citations
6.
Werning, C. (1976). The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension. Journal of Molecular Medicine. 54(15). 727–734. 5 indexed citations
7.
Werning, C. (1976). [Renin secreting kidney tumors].. PubMed. 47(1). 82–4. 4 indexed citations
8.
Vetter, H., et al.. (1974). EPISODIC SECRETION OF ALDOSTERONE IN PRIMARY ALDOSTERONISM: RELATIONSHIP TO CORTISOL. Clinical Endocrinology. 3(1). 41–48. 39 indexed citations
9.
Werning, C. (1972). Das Renin-Angiotensin-Aldosteron-System. Thieme eBooks. 10 indexed citations
10.
Werning, C & W Siegenthaler. (1972). [Diagnosis of chronic pyelonephritis].. PubMed. 63(58). 3160–2. 1 indexed citations
11.
Werning, C, et al.. (1972). Therapie der chronischen Pyelonephritis*. DMW - Deutsche Medizinische Wochenschrift. 97(6). 202–203. 1 indexed citations
12.
Werning, C, et al.. (1972). Diagnostik der chronischen Pyelonephritis*. DMW - Deutsche Medizinische Wochenschrift. 97(6). 200–202. 3 indexed citations
13.
Werning, C, O Stadelmann, S. E. Miederer, et al.. (1971). Der Einfluß einer Carbenoxolon-Therapie auf das Renin-Angiotensin-Aldosteron-System. Journal of Molecular Medicine. 49(23). 1285–1289. 6 indexed citations
14.
15.
Werning, C, et al.. (1970). [Importance of renin-angiotensin-aldosterone system in diverse forms of hypertension].. PubMed. 59(20). 730–7. 4 indexed citations
16.
Werning, C & W Siegenthaler. (1970). Richtlinien der Diuretika-Therapie. DMW - Deutsche Medizinische Wochenschrift. 95(10). 523–526. 3 indexed citations
17.
Werning, C, et al.. (1970). Die Plasma-Renin-Aktivität beim Phäochromozytom*. DMW - Deutsche Medizinische Wochenschrift. 95(3). 117–125. 11 indexed citations
18.
Werning, C, et al.. (1970). [Effects of extended application of hydrochlorothiazide on the plasma renin activity and electrolyte balance in adrenalectomized patients].. PubMed. 20(12). 1935–9. 2 indexed citations
19.
Werning, C, et al.. (1969). Die Wirkung länger dauernder Hydrochlorothiazid-Gaben auf die Plasma-Renin-Aktivität und die Aldosteron-Exkretionsrate bei Normalpersonen. Journal of Molecular Medicine. 47(6). 318–324. 11 indexed citations
20.
Werning, C, et al.. (1969). [Behavior of plasma renin activity after orthostatism and following reclining rest position in normal persons].. PubMed. 58(9). 996–1001. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quentin B. Deming Breakdown of academic impact, for papers by N. Papanicolaou Breakdown of academic impact, for papers by P. Speckart Breakdown of academic impact, for papers by Francis L. Stutzman Breakdown of academic impact, for papers by E. Podjarny Breakdown of academic impact, for papers by T. Mountokalakis Breakdown of academic impact, for papers by Leroy E. Duncan Breakdown of academic impact, for papers by Lawrence Levine Breakdown of academic impact, for papers by Markus Küng Breakdown of academic impact, for papers by Andre J. Premen
Rankless by CCL
2026